Comparison of six commercially available SARS-CoV-2 antibody assays—Choice of assay depends on intended use

OBJECTIVES: Evaluate six commercial serological assays for detection of IgA, IgM or IgG SARS-CoV-2 antibodies in different disease severities. METHODS: Three lateral flow tests (LFTs) (Acro IgM/IgG, CTK IgM/IgG, Livzon IgM/IgG) and three ELISA assays (Euroimmun IgA and IgG, Wantai IgM) were included...

Descripción completa

Detalles Bibliográficos
Autores principales: Nilsson, Anna Christine, Holm, Dorte Kinggaard, Justesen, Ulrik Stenz, Gorm-Jensen, Thøger, Andersen, Nanna Skaarup, Øvrehus, Anne, Johansen, Isik Somuncu, Michelsen, Jens, Sprogøe, Ulrik, Lillevang, Søren Thue
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7726521/
https://www.ncbi.nlm.nih.gov/pubmed/33310021
http://dx.doi.org/10.1016/j.ijid.2020.12.017

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7726521/
https://www.ncbi.nlm.nih.gov/pubmed/33310021
http://dx.doi.org/10.1016/j.ijid.2020.12.017

Ejemplares similares